Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level

Velayati A. A., Farnia P., Masjedi M. R., Ibrahim T. A., Tabarsi P., Haroun R. Z., Kuan H. O., Ghanavi J., Farnia P., Varahram M.

Source: Eur Respir J 2009; 34: 1202-1203

Journal Issue: November

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Velayati A. A., Farnia P., Masjedi M. R., Ibrahim T. A., Tabarsi P., Haroun R. Z., Kuan H. O., Ghanavi J., Farnia P., Varahram M.. Totally drug-resistant tuberculosis strains: evidence of adaptation at the cellular level. Eur Respir J 2009; 34: 1202-1203

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Induction of M. tuberculosis (MTB) drug resistance (DR) mutations in HIV-infected hosts and pathways of further spread of the evolutionary successful drug-resistant MTB clonal lines Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017
Defining optimal fluoroquinolone exposure against Mycobacterium tuberculosis: contribution of murine studies Source: Eur Respir J, 57 (4) 2004315; 10.1183/13993003.04315-2020 Year: 2021
Characterisation of patients with multiple isolates of different species of non-tuberculous mycobacteria: a new phenomenon? Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections Year: 2009
Genetic diversity of M. tuberculosis isolates from patients with drug-resistant TB in Japan Source: International Congress 2018 – Current practices in and attitudes to screening for tuberculosis, and a discussion about genetic diversity Year: 2018
Comparative analysis of M. tuberculosis drug susceptibility tests results in new multidrug-resistant tuberculosis cases and their confirmed contacts. Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis Year: 2020
In vitro susceptibility testing and totally drug-resistant tuberculosis Source: Eur Respir J 2013; 42: 291-292 Year: 2013
In vitro susceptibility testing and totally drug-resistant tuberculosis Source: Eur Respir J 2013; 42: 292 Year: 2013
Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence Source: Eur Respir J 2016; 47: 394-402 Year: 2016
Multidrug-resistant tuberculosis in children: evidence from global surveillance Source: Eur Respir J 2013; 42: 701-707 Year: 2013
Multidrug- and rifampicin-resistant tuberculosis (MDR/RR-TB) : global response Source: International Congress 2017 – Update on TB: latest news Year: 2017
Clinical and operational value of the extensively drug-resistant tuberculosis definition Source: Eur Respir J 2007; 30: 623-626 Year: 2007
WHO guidance on multidrug-resistant tuberculosis treatment: using and communicating the evidence Source: Eur Respir J, 55 (3) 1902325; 10.1183/13993003.02325-2019 Year: 2020
Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001
From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli Source: International Congress 2019 – Tuberculosis: from basic science to patient care Year: 2019
From environmental bacteria to obligate pathogen: the study of adaptations enhancing the persistence of tuberculosis bacilli Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020
The WHO strategy for TB control and elimination Source: Eur Respir Mon 2012; 58: 242-253 Year: 2012